Imoto I - Search Results

1

SIX1 promotes epithelial-mesenchymal transition in colorectal cancer through ZEB1 activation.

Ono H, Imoto I, Kozaki K, Tsuda H, Matsui T, Kurasawa Y, Muramatsu T, Sugihara K, Inazawa J. Ono H, et al. Among authors: imoto i. Oncogene. 2012 Nov 22;31(47):4923-34. doi: 10.1038/onc.2011.646. Epub 2012 Jan 30. Oncogene. 2012. PMID: 22286765

2

Genomic loss and epigenetic silencing of very-low-density lipoprotein receptor involved in gastric carcinogenesis.

Takada H, Imoto I, Tsuda H, Nakanishi Y, Sakakura C, Mitsufuji S, Hirohashi S, Inazawa J. Takada H, et al. Among authors: imoto i. Oncogene. 2006 Oct 19;25(49):6554-62. doi: 10.1038/sj.onc.1209657. Epub 2006 May 22. Oncogene. 2006. PMID: 16715143

3

A novel amplification target, DUSP26, promotes anaplastic thyroid cancer cell growth by inhibiting p38 MAPK activity.

Yu W, Imoto I, Inoue J, Onda M, Emi M, Inazawa J. Yu W, et al. Among authors: imoto i. Oncogene. 2007 Feb 22;26(8):1178-87. doi: 10.1038/sj.onc.1209899. Epub 2006 Aug 21. Oncogene. 2007. PMID: 16924234

4

Frequent methylation-associated silencing of a candidate tumor-suppressor, CRABP1, in esophageal squamous-cell carcinoma.

Tanaka K, Imoto I, Inoue J, Kozaki K, Tsuda H, Shimada Y, Aiko S, Yoshizumi Y, Iwai T, Kawano T, Inazawa J. Tanaka K, et al. Among authors: imoto i. Oncogene. 2007 Sep 27;26(44):6456-68. doi: 10.1038/sj.onc.1210459. Epub 2007 Apr 16. Oncogene. 2007. PMID: 17438526

5

PRTFDC1, a possible tumor-suppressor gene, is frequently silenced in oral squamous-cell carcinomas by aberrant promoter hypermethylation.

Suzuki E, Imoto I, Pimkhaokham A, Nakagawa T, Kamata N, Kozaki KI, Amagasa T, Inazawa J. Suzuki E, et al. Among authors: imoto i. Oncogene. 2007 Dec 13;26(57):7921-32. doi: 10.1038/sj.onc.1210589. Epub 2007 Jun 18. Oncogene. 2007. PMID: 17599052

6

POU2AF1, an amplification target at 11q23, promotes growth of multiple myeloma cells by directly regulating expression of a B-cell maturation factor, TNFRSF17.

Zhao C, Inoue J, Imoto I, Otsuki T, Iida S, Ueda R, Inazawa J. Zhao C, et al. Among authors: imoto i. Oncogene. 2008 Jan 3;27(1):63-75. doi: 10.1038/sj.onc.1210637. Epub 2007 Jul 9. Oncogene. 2008. PMID: 17621271

7

Stabilization of phenotypic plasticity through mesenchymal-specific DNA hypermethylation in cancer cells.

Kurasawa Y, Kozaki K, Pimkhaokham A, Muramatsu T, Ono H, Ishihara T, Uzawa N, Imoto I, Amagasa T, Inazawa J. Kurasawa Y, et al. Among authors: imoto i. Oncogene. 2012 Apr 12;31(15):1963-74. doi: 10.1038/onc.2011.373. Epub 2011 Aug 29. Oncogene. 2012. PMID: 21874048

8

RGC32, a novel p53-inducible gene, is located on centrosomes during mitosis and results in G2/M arrest.

Saigusa K, Imoto I, Tanikawa C, Aoyagi M, Ohno K, Nakamura Y, Inazawa J. Saigusa K, et al. Among authors: imoto i. Oncogene. 2007 Feb 22;26(8):1110-21. doi: 10.1038/sj.onc.1210148. Epub 2006 Dec 4. Oncogene. 2007. PMID: 17146433

9

Epigenetic silencing of prostaglandin E receptor 2 (PTGER2) is associated with progression of neuroblastomas.

Sugino Y, Misawa A, Inoue J, Kitagawa M, Hosoi H, Sugimoto T, Imoto I, Inazawa J. Sugino Y, et al. Among authors: imoto i. Oncogene. 2007 Nov 22;26(53):7401-13. doi: 10.1038/sj.onc.1210550. Epub 2007 May 28. Oncogene. 2007. PMID: 17533365

10

DEK oncoprotein regulates transcriptional modifiers and sustains tumor initiation activity in high-grade neuroendocrine carcinoma of the lung.

Shibata T, Kokubu A, Miyamoto M, Hosoda F, Gotoh M, Tsuta K, Asamura H, Matsuno Y, Kondo T, Imoto I, Inazawa J, Hirohashi S. Shibata T, et al. Among authors: imoto i. Oncogene. 2010 Aug 19;29(33):4671-81. doi: 10.1038/onc.2010.217. Epub 2010 Jun 14. Oncogene. 2010. PMID: 20543864

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

341 results

Search Page

Filters